Shaanxi Jianhua Biopharmaceutical Co., Ltd.

China

Back to Profile

1-2 of 2 for Shaanxi Jianhua Biopharmaceutical Co., Ltd. Sort by
Query
Aggregations
Jurisdiction
        World 1
        United States 1
IPC Class
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli 2
A61P 13/08 - Drugs for disorders of the urinary system of the prostate 2
A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells 1
A61K 35/586 - TurtlesTortoises, e.g. terrapins 1
A61K 35/618 - Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs 1
See more
Found results for  patents

1.

Combined external medicine for treating prostate diseases

      
Application Number 16198870
Grant Number 10702557
Status In Force
Filing Date 2018-11-22
First Publication Date 2019-03-28
Grant Date 2020-07-07
Owner Shaanxi Jianhua Biopharmaceutical Co., Ltd. (China)
Inventor
  • He, Jian
  • Wang, Hua

Abstract

The invention provides a combined external medicine for treating prostate diseases and a method using the same. The combined external medicine includes a pre-immune composition comprising multi-immune powder and a noble bottle tree decoction, a lesion active composition comprising the multi-immune powder and a first medical decoction prepared from a first Chinese medical composition for treating prostate diseases, and a double rib active composition comprising the multi-immune powder and a second medical decoction prepared from a second Chinese medical composition for conditioning liver and kidney. The method includes applying the pre-immune composition on skin of lesion part and skin of the left and right ribs; waiting for 5-10 minutes; applying the lesion active composition and the double rib active composition on the skin of the lesion part and skin of the left and right ribs; and airing for 10-40 minutes.

IPC Classes  ?

  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
  • A61K 35/62 - LeechesWorms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
  • A61K 36/8966 - Fritillaria, e.g. checker lily or mission bells
  • A61K 36/902 - Sparganiaceae (Bur-reed family)
  • A61K 36/904 - Stemonaceae (Stemona family), e.g. croomia
  • A61K 36/8969 - Polygonatum (Solomon's seal)
  • A61K 36/9066 - Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
  • A61K 35/618 - Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
  • A61K 35/63 - Arthropods
  • A61K 35/586 - TurtlesTortoises, e.g. terrapins
  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61P 17/00 - Drugs for dermatological disorders
  • A61P 13/08 - Drugs for disorders of the urinary system of the prostate
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 35/64 - Insects, e.g. bees, wasps or fleas
  • A61K 36/076 - Poria
  • A61K 36/39 - Convolvulaceae (Morning-glory family), e.g. bindweed
  • A61K 36/40 - Cornaceae (Dogwood family)
  • A61K 36/481 - Astragalus (milkvetch)
  • A61K 36/64 - Orobanchaceae (Broom-rape family)
  • A61K 36/65 - Paeoniaceae (Peony family), e.g. Chinese peony
  • A61K 36/884 - Alismataceae (Water-plantain family)
  • A61K 36/894 - Dioscoreaceae (Yam family)
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

2.

COMBINED EXTERNALLY-APPLIED DRUG FOR TREATING PROSTATIC DISEASES

      
Application Number CN2018081059
Publication Number 2018/210066
Status In Force
Filing Date 2018-03-29
Publication Date 2018-11-22
Owner SHAANXI JIANHUA BIOPHARMACEUTICAL CO., LTD. (China)
Inventor
  • He, Jian
  • Wang, Hua

Abstract

A combined externally-applied drug for treating prostatic diseases, characterized by comprising three components, which are a pre-immunization component, a focus active component, and a double-rib active component. The pre-immunization component consists of multi-immunization powder and a Sterculia nobilis decoction; the focus active component consists of multi-immunization powder and a traditional Chinese medicine for treating prostatic diseases; the double-rib active component consists of multi-immunization powder and a traditional Chinese medicine for conditioning the liver and the kidney. The multi-immunization powder is i26 immunization egg powder.

IPC Classes  ?

  • A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
  • A61K 36/185 - Magnoliopsida (dicotyledons)
  • A61K 9/06 - OintmentsBases therefor
  • A61P 13/08 - Drugs for disorders of the urinary system of the prostate